These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18629788)

  • 1. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.
    Giovanella L; Crippa S; Cariani L
    Int J Biol Markers; 2008; 23(2):129-31. PubMed ID: 18629788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
    Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
    Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
    Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
    Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
    Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
    Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin-like polypeptides without apparent biological activity in a patient with recurrent medullary thyroid carcinoma.
    Nakajima K; Jinkawa I; Hirota T; Ikeda T; Tugawa M; Minami Y; Hanada M
    Intern Med; 1995 Sep; 34(9):896-900. PubMed ID: 8580565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
    Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
    Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of a hereditary medullary thyroid carcinoma case with normal preoperative serum calcitonin levels.
    Zhang G; Jiang Y; Zhang S; Zhao L; Fan J; Zhang Z; Ma J; Chen R; Xu Y
    Pathol Res Pract; 2019 Oct; 215(10):152529. PubMed ID: 31409511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
    Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The routine immunohistochemical diagnosis and surgical treatment of medullary carcinoma of the thyroid].
    Gavrailov M; Petkov R; Mladenov B; Todorov G; Kŭtev N
    Khirurgiia (Sofiia); 1995; 48(2):17-9. PubMed ID: 8531439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
    Yip DT; Hassan M; Pazaitou-Panayiotou K; Ruan DT; Gawande AA; Gaz RD; Moore FD; Hodin RA; Stephen AE; Sadow PM; Daniels GH; Randolph GW; Parangi S; Lubitz CC
    Surgery; 2011 Dec; 150(6):1168-77. PubMed ID: 22136837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid cancer with undetectable serum calcitonin.
    Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
    J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.